Statements of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Statement of Cash Flows [Abstract]
Net Income	$ 13,396,769	$ 10,256,362
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,817,205	2,421,177
Abandoned patents or software written off	250,523	66,619
Provision for bad debts	1,806,299	1,544,521
Deferred income tax benefit	(2,682,405)	(2,473,892)
Gain on sale of equipment		(557,473)
Loss on disposition of equipment	657,350
Gain on litigation settlement		(755,500)
Impairment on management agreement		357,500
Compensatory element of stock issuances	223,000	415,021
Stock issued for costs and expenses	531,825
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	(4,044,002)	(3,717,440)
Notes receivable	95,623	120,976
Costs and estimated earnings in excess of Billings on uncompleted contracts	(314,067)	682,854
Inventories	(366,448)	117,861
Prepaid expenses and other current assets	46,967	(698,284)
Other assets	131,811	(204,037)
Increase (decrease) in operating liabilities, net:
Accounts payable	(270,482)	628,033
Other current liabilities	295,219	(414,402)
Customer advances	68,943	(567,914)
Billings in excess of costs and estimated earnings on uncompleted contracts		142,217
Other liabilities	(268,261)	253,559
Due to related medical practices	3,955	1,885
Income tax payable	(19,501)	(80,499)
NET CASH PROVIDED BY OPERATING ACTIVITIES	13,360,323	7,539,144
Cash Flows from Investing Activities:
Purchases of property and equipment	(620,697)	(1,135,382)
Cost of acquisition		(40,000,000)
Cost of patents	(214,211)	(159,907)
NET CASH USED IN INVESTING ACTIVITIES	(834,908)	(41,295,289)
Cash Flows from Financing Activities
Proceeds from debt		14,689,646
Proceeds from sale of equipment		700,000
Repayment of borrowings and capital lease obligations	(4,400,128)	(1,821,617)
Repayment of notes receivable from employee stockholders	15,992	15,993
Stock option exercised	30,600
Distributions to noncontrolling interests	(4,965,770)	(1,799,950)
Redemption of noncontroling Interests	(4,965,770)	(1,799,950)
Buyout of noncontroling Interest		564,315
Proceeds from noncontrolling interest		19,800,000
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	(10,444,406)	29,594,857
Net Increase in Cash and Cash Equivalents	2,081,009	(4,161,288)
Cash and Cash Equivalents Beginning of Year	7,870,727	12,032,015
Cash and Cash Equivalents - End of Year	$ 9,951,736	$ 7,870,727